Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
Paige McLean DiazAugustin VannierAmit D JoshiRachael E MahleEric M PrzybyszewskiKathleen CoreyRaymond T ChungJay LutherRussell P GoodmanEsperance Ak SchaeferPublished in: Clinical and translational gastroenterology (2023)
FGF-21 performs well as a predictive biomarker to distinguish severe AH from AC and may be helpful in the management and clinical investigation of patients with severe alcohol-associated liver diseases.